本页面由Tiger Trade Technology Pte. Ltd.提供服务

ProQR Therapeutics N.V.

1.48
-0.1400-8.64%
盘后:1.550.0700+4.73%19:30 EDT
成交量:118.62万
成交额:182.70万
市值:2.09亿
市盈率:-3.23
高:1.62
开:1.62
低:1.48
收:1.62
52周最高:3.10
52周最低:1.33
股本:1.41亿
流通股本:1.01亿
量比:1.36
换手率:1.17%
股息:- -
股息率:- -
每股收益(TTM):-0.4578
每股收益(LYR):-0.4702
净资产收益率:-57.40%
总资产收益率:-19.76%
市净率:2.35
市盈率(LYR):-3.15

数据加载中...

2020/02/26

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/29

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/28

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/08

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/17

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/28

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]